Elan jump sets positive tone on ISEQ

Shares in pharmaceutical company Elan jumped 35c to €3.30 today, on the back of some good news from the States.

Data presented at the 57th annual American Academy of Neurology (AAN) meeting in Miami showed treatment with under-fire multiple sclerosis (MS) drug Tysabri led to a significant reduction in progression of the disease.